{"product_id":"genusplc-bcg-matrix","title":"Genus Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVisual. Strategic. Downloadable.\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the secrets to your company's product portfolio with the Genus BCG Matrix. Understand at a glance which products are driving growth, which are stable earners, and which require careful consideration. This powerful tool helps you make informed decisions about resource allocation and future investments.\u003c\/p\u003e\n\u003cp\u003eDon't settle for a partial view; purchase the full BCG Matrix to gain a comprehensive understanding of your product landscape. You'll receive detailed insights into each quadrant, actionable strategies for optimizing your portfolio, and the clarity needed to navigate market dynamics with confidence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePIC ex-China Growth Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGenus's PIC ex-China Growth Markets are shining stars in their BCG matrix.  In the first half of fiscal year 2025, royalty revenue from these regions saw a significant uptick, alongside a healthy increase in adjusted operating profit. This indicates robust demand and successful market penetration.\u003c\/p\u003e\n\u003cp\u003eThe growth isn't confined to a single area; North America, Latin America, and Europe are all contributing to PIC's expanding market share. This broad-based expansion highlights the effectiveness of Genus's strategy in diverse geographical landscapes.\u003c\/p\u003e\n\u003cp\u003eThe overall global animal genetics market is experiencing expansion, and Genus is strategically positioned to capitalize on this trend. Specifically, the porcine genetics sector in these ex-China markets represents a prime opportunity for continued high growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePRRS Resistant Pig (PRP) Commercialization\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Porcine Reproductive and Respiratory Syndrome (PRRS) Resistant Pig (PRRSv-Resist™) represents a potential star for Genus. With FDA approval anticipated in 2025, this gene-edited innovation tackles a persistent and costly industry problem, positioning it for significant future revenue growth.\u003c\/p\u003e\n\u003cp\u003eThe commercialization of the PRRSv-Resist™ pig is a key strategic focus, aiming to capture a substantial share of the global swine market. This product addresses a critical unmet need, offering a biological solution to a disease that caused an estimated $664 million in losses annually in the US alone in 2021.\u003c\/p\u003e\n\u003cp\u003eBeyond the US, Genus has submitted regulatory applications in Canada and Japan, signaling a clear intent to pursue a broad international market for its PRRSv-Resist™ technology. This expansion strategy underscores the product's high growth potential and its role as a future market leader.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntelliGen Technologies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIntelliGen Technologies, developed by Genus, is a groundbreaking platform designed to screen and process semen, specifically selecting for desirable traits like the female gender. This innovation is particularly vital for dairy farmers aiming to boost breeding efficiency.\u003c\/p\u003e\n\u003cp\u003eThe technology's sophistication and its application within the expanding market for precision breeding solidify its position as a key Star product for Genus. For instance, Genus reported that its ABS global business, which includes IntelliGen, saw its revenue grow by 8% in the first half of fiscal year 2024, reaching £266 million, demonstrating strong market adoption.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh-Value Bovine Genetics (Sexed \u0026amp; Beef)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGenus's strategic emphasis on high-value bovine genetics, encompassing both sexed semen and beef genetics, highlights a segment poised for significant expansion. This focus directly addresses the increasing demand for enhanced animal performance and agricultural efficiency.\u003c\/p\u003e\n\u003cp\u003eThe company has experienced impressive growth in its sexed semen volume. For instance, in the first half of fiscal year 2024, Genus reported a 10% increase in sexed female sales volume. This upward trend is further bolstered by strategic moves, such as acquiring the remaining interest in De Novo Genetics, which significantly enhances their beef genetics portfolio.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eSexed semen volume growth:\u003c\/strong\u003e Genus saw a 10% increase in sexed female sales volume in H1 FY24.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBeef genetics expansion:\u003c\/strong\u003e Acquisition of the remaining interest in De Novo Genetics strengthens their offering in this high-value segment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMarket demand:\u003c\/strong\u003e These genetic advancements cater to specific market needs for improved animal efficiency and productivity.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOverall Global Animal Genetics Market Position\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGenus holds a dominant position in the global animal genetics market, a sector anticipated to expand substantially in the coming decade.  The company's extensive offerings in both pig and bovine genetics, supported by continuous research and development, are well-positioned to benefit from this market expansion.\u003c\/p\u003e\n\u003cp\u003eThis strong standing within a high-growth industry clearly defines Genus as a Star within the BCG matrix.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eGlobal Animal Genetics Market Growth:\u003c\/strong\u003e The animal genetics market is projected to grow at a compound annual growth rate (CAGR) of approximately 7-8% through 2030, driven by increasing demand for protein and advancements in breeding technologies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGenus's Market Share:\u003c\/strong\u003e Genus is a leading player, holding a significant share in key segments of the global bovine and porcine genetics markets.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eR\u0026amp;D Investment:\u003c\/strong\u003e In fiscal year 2023, Genus reported investing over $80 million in research and development, a crucial factor in maintaining its competitive edge and driving innovation in animal genetics.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDiversified Portfolio:\u003c\/strong\u003e The company's balanced portfolio across species and geographies provides resilience and multiple avenues for capturing market growth.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGenus: Stars Shine Bright in Growth Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStars represent products or business units with high market share in a high-growth industry. Genus's PIC ex-China growth markets exemplify this, showing strong royalty revenue and profit growth in the first half of fiscal year 2025, driven by broad geographic expansion.\u003c\/p\u003e\n\u003cp\u003eThe PRRSv-Resist™ pig is a prime example of a Star, addressing a significant industry problem with an estimated annual loss of $664 million in the US due to PRRS. FDA approval anticipated in 2025 and regulatory submissions in Canada and Japan highlight its high growth potential.\u003c\/p\u003e\n\u003cp\u003eIntelliGen Technologies, enhancing breeding efficiency in dairy, is another Star. Genus's ABS business, including IntelliGen, saw an 8% revenue increase in H1 FY24, reaching £266 million, indicating strong market adoption.\u003c\/p\u003e\n\u003cp\u003eGenus's focus on high-value bovine genetics, particularly sexed semen, is a Star segment. Sexed female sales volume grew 10% in H1 FY24, further strengthened by the acquisition of De Novo Genetics, bolstering their beef genetics portfolio.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eProduct\/Segment\u003c\/td\u003e\n\u003ctd\u003eMarket Growth\u003c\/td\u003e\n\u003ctd\u003eMarket Share\u003c\/td\u003e\n\u003ctd\u003eFinancial Highlight (H1 FY25 unless noted)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePIC ex-China Growth Markets\u003c\/td\u003e\n\u003ctd\u003eHigh\u003c\/td\u003e\n\u003ctd\u003eHigh\u003c\/td\u003e\n\u003ctd\u003eSignificant uptick in royalty revenue and adjusted operating profit.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePRRSv-Resist™ Pig\u003c\/td\u003e\n\u003ctd\u003eHigh (potential)\u003c\/td\u003e\n\u003ctd\u003eHigh (potential)\u003c\/td\u003e\n\u003ctd\u003eFDA approval anticipated 2025; addresses $664M annual US loss from PRRS.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntelliGen Technologies\u003c\/td\u003e\n\u003ctd\u003eHigh\u003c\/td\u003e\n\u003ctd\u003eHigh\u003c\/td\u003e\n\u003ctd\u003eABS business revenue grew 8% in H1 FY24 (£266M).\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSexed Semen \u0026amp; Beef Genetics\u003c\/td\u003e\n\u003ctd\u003eHigh\u003c\/td\u003e\n\u003ctd\u003eHigh\u003c\/td\u003e\n\u003ctd\u003e10% increase in sexed female sales volume (H1 FY24).\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eThe Genus BCG Matrix provides strategic guidance by classifying business units based on market share and growth, highlighting which to invest in, hold, or divest.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a clear, visual framework to identify and address underperforming business units, alleviating the pain of strategic indecision.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEstablished PIC Royalty Model\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGenus's established royalty model within its PIC segment, especially in developed markets beyond China, is a clear cash cow. This segment consistently delivers robust revenue and profit, benefiting from a high market share in mature, stable markets. \u003c\/p\u003e\n\u003cp\u003eThe stability of these established markets means Genus can rely on consistent cash flow with minimal need for increased marketing or promotional spending. This dependable income stream is crucial for funding other business ventures or investments. \u003c\/p\u003e\n\u003cp\u003eFor instance, in 2024, the PIC segment outside China is projected to contribute significantly to Genus's overall profitability, with royalty revenues expected to grow by a steady 4% year-over-year, demonstrating its mature yet resilient market position. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConventional ABS Dairy Genetics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGenus's conventional dairy genetics, particularly through its ABS division, represents a strong Cash Cow. This segment benefits from a substantial market share in mature dairy markets worldwide, ensuring consistent revenue streams.\u003c\/p\u003e\n\u003cp\u003eWhile the growth trajectory for conventional genetics is more moderate, it generates significant and dependable cash flow, which is crucial for funding other areas of the business. For instance, in the fiscal year ending June 30, 2024, Genus reported that its ABS division continued to be a bedrock of profitability, with stable demand in key dairy-producing nations.\u003c\/p\u003e\n\u003cp\u003eThe company's Value Acceleration Programme is actively working to boost the efficiency and profitability of these core operations, further solidifying their status as reliable Cash Cows. This focus ensures that these established genetic lines continue to deliver strong financial performance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eValue Acceleration Programme (VAP) Benefits\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe Value Acceleration Programme (VAP) within Genus's ABS segment is a prime example of a cash cow.  This initiative has significantly boosted profitability by focusing on operational efficiencies and smarter resource use.  For instance, in 2024, the ABS segment reported a 15% increase in operating profit, largely attributed to VAP's cost-saving measures, generating substantial free cash flow.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCore Breeding Animal Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe direct sale of core breeding animals, encompassing both the PIC and ABS segments, forms a bedrock revenue source for Genus. These animals are highly sought after by farmers for their proven genetic advancements, ensuring consistent and dependable income for the company.\u003c\/p\u003e\n\u003cp\u003eThese offerings likely hold substantial market share within their specific agricultural niches. For instance, in 2024, Genus reported that its PIC business continued to be a leader in porcine genetics, driven by strong demand for its high-performance breeding stock. Similarly, ABS, its cattle genetics division, saw robust sales of elite breeding animals, reflecting the ongoing need for genetic improvement in dairy and beef herds.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eHigh Market Share:\u003c\/strong\u003e Genus's breeding animals are leaders in their respective agricultural sectors.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConsistent Revenue:\u003c\/strong\u003e Direct sales provide a stable and reliable income stream.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFarmer Demand:\u003c\/strong\u003e Farmers rely on these animals for essential genetic improvements.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e2024 Performance:\u003c\/strong\u003e Both PIC and ABS divisions showed strong sales of breeding stock.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGenetic Trait and Performance Testing Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eGenetic trait and performance testing services are a cornerstone for Genus, contributing a significant portion to the company's revenue within the animal genetics sector. These offerings are crucial for enhancing breeding efficiency and are considered a mature product line with a well-established market position.\u003c\/p\u003e\n\u003cp\u003eThese services represent a classic Cash Cow for Genus, characterized by their high market share and relatively low growth potential. In 2024, the global animal genetics market was valued at approximately $5.2 billion, with testing and data services forming a substantial segment.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eHigh Market Share:\u003c\/strong\u003e Genus holds a dominant position in providing genetic trait and performance testing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSteady Income Stream:\u003c\/strong\u003e These services generate consistent revenue due to their essential nature in modern animal agriculture.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMature Market:\u003c\/strong\u003e The demand for these services is stable, reflecting a well-established and understood market.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLow Growth:\u003c\/strong\u003e While essential, the growth rate for these services is typically moderate, characteristic of mature offerings.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGenus's PIC Segment: A Cash Cow in Developed Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGenus's established royalty model within its PIC segment, particularly in developed markets outside China, functions as a definitive cash cow. This segment consistently delivers substantial revenue and profit, underpinned by a high market share in mature, stable markets.\u003c\/p\u003e\n\u003cp\u003eThe stability of these established markets means Genus can rely on consistent cash flow with minimal need for increased marketing or promotional spending. This dependable income stream is crucial for funding other business ventures or investments.\u003c\/p\u003e\n\u003cp\u003eFor instance, in the fiscal year ending June 30, 2024, Genus reported that its PIC segment outside China continued to be a bedrock of profitability, with royalty revenues demonstrating stable demand in key global markets.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eSegment\u003c\/td\u003e\n\u003ctd\u003eBCG Category\u003c\/td\u003e\n\u003ctd\u003e2024 Revenue Contribution (Est.)\u003c\/td\u003e\n\u003ctd\u003eMarket Share (Est.)\u003c\/td\u003e\n\u003ctd\u003eGrowth Outlook\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePIC (Developed Markets)\u003c\/td\u003e\n\u003ctd\u003eCash Cow\u003c\/td\u003e\n\u003ctd\u003eSignificant\u003c\/td\u003e\n\u003ctd\u003eHigh\u003c\/td\u003e\n\u003ctd\u003eStable\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eABS (Conventional Genetics)\u003c\/td\u003e\n\u003ctd\u003eCash Cow\u003c\/td\u003e\n\u003ctd\u003eSubstantial\u003c\/td\u003e\n\u003ctd\u003eHigh\u003c\/td\u003e\n\u003ctd\u003eModerate\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You’re Viewing Is Included\u003c\/span\u003e\u003cbr\u003eGenus BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe preview you are currently viewing is the identical, fully functional Genus BCG Matrix document you will receive upon purchase. This means no watermarks, no demo content, and no hidden surprises – just a professionally formatted and analysis-ready tool designed to provide clear strategic insights for your business.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":55610829865337,"sku":"genusplc-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/genusplc-bcg-matrix.png?v=1754747022","url":"https:\/\/growthsharematrix.com\/products\/genusplc-bcg-matrix","provider":"Growth Share Matrix","version":"1.0","type":"link"}